Erisyon logo
VerifiedBiotechnology Research· Founded 2018

Erisyon

Erisyon is transforming the field of proteomics with the world’s first single molecule protein sequencer. With unprecedented sensitivity and scalability for proteomics, Erisyon enables new applications across the Life Sciences Erisyon has emerged from the University of Texas at Austin to commercialize the world’s first single molecule protein sequencer. Inheriting work developed over the course of the past decade at UT’s Center for Systems and Synthetic Biology, Erisyon was founded by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.

7-day free trial · no credit card

HeadquartersAustin, United StatesEmployees7(1 to 10)Annual revenue$100M to <$1BFounded year2018Websiteerisyon.comLinkedIn profileLinkedIn

Verified contacts

9

available on Kipplo

LinkedIn employees

7

1 to 10 range

Open roles

no listings

Distinct roles

8

indexed titles

Tech stack

0

tools in use

Monthly traffic

23

organic / mo

Sign up free to see all 9 verified contacts at Erisyon

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

9 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Erisyon

8 distinct titles indexed · top 8 shown.

  • 1co-founder and chief technology officer
  • 1co-founder, chair of scientific advisory board
  • 1informatics lead
  • 1laboratory technician
  • 1lead researcher of the technology access facility
  • 1research and development scientist
  • 1scientist
  • 1software engineer

Sign up to unlock all 9 contacts at Erisyon

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 9 verified contacts at Erisyon

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Erisyon | Kipplo Discover